RedC Biotech
PrivateLast Round
Grant
Mar 22, 2022
Total Funding Raised
$1.9M
Company Overview
RedC Biotech operates in Healthcare & Life Sciences and is based in Caesarea. Its latest recorded funding round was a Grant round in March 2022.
RedC Biotech is a biotechnology company developing an industrial process to produce universal red blood cells from stem cells for medical transfusions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RedC Biotech Comparables
Compare RedC Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Safi Biotherapeutics | 86% | |
| KaloCyte, Inc. | 77% | |
| HemostOD SA | 75% |
For institutional investors. Book with your work email.
RedC Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 22, 2022 | ||||
| Seed | May 1, 2020 | ||||
| Pre Seed | Apr 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RedC Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aviram Family Foundation | Grant |
| PipelBiz | Pre Seed, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 52% MoM.
- Oct 26, 2024
Monthly visitors grew 372% MoM, reaching 770.
For institutional investors. Book with your work email.
RedC Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RedC Biotech's valuation, stock price, and market status.
Is RedC Biotech a public or private company?
RedC Biotech is a private company.
What is the current stock price of RedC Biotech?
RedC Biotech is a private company, so its shares have no public market price. Caplight tracks RedC Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RedC Biotech worth (valuation)?
Valuation information for RedC Biotech is not publicly available.
Can I buy RedC Biotech stock?
RedC Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RedC Biotech's last funding round?
RedC Biotech's most recent funding round was Grant on March 22, 2022.
Who are the main investors in RedC Biotech?
Key investors in RedC Biotech include PipelBiz.
Will RedC Biotech IPO soon?
No public IPO plans have been announced for RedC Biotech.
How can I track RedC Biotech secondary market activity?
Caplight tracks bids, offers, and trades in RedC Biotech's shares on secondary markets.